NL-OMON35875尚未招募不适用
Ovarian hyperstimulation in women with estrogen-receptor positive breastcancer who opt for embryo- or oocyte freezing: Is the Tamoxifen dosage sufficient to protect women against estrogen exposure? (TAMOXI project: a pilot study). - TAMOXI project
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Women who are of reproductive age (18- 40 yrs), who suffer from estrogen- receptor positive breast cancer and opt for embryo- or oocyte freezing.
排除标准
- •1)Women who are unwilling or unable to sign the informed consent form
- •2)Women who are not in good enough medical condition to undergo ovarian hormone stimulation and ovum pick up.
- •3) Women who need medication which opposes the efficacy of tamoxifen (e.g. fluotexine)
研究者
相似试验
已完成
3 期
Stimulation of the ovaries in women with breast cancer undergoing fertility preservation: alternative versus standard stimulation protocols; the STIM-trialmamma carcinoma1000629110018515breast cancerNL-OMON47167Academisch Medisch Centrum149
进行中（未招募）
1 期
The effectiveness of controlled ovarian stimulation in women with breast cancerOvarian stimulation in women with breast cancer prior to chemotherapyEUCTR2013-000801-21-NLAcademic Medical Center159
已完成
不适用
Ovarian stimulation with follicle stimulating hormone (r-FSH) for women with high early follicular FSH and intra-uterine insemination (IUI) indicatioISRCTN14825568VU University Medical Centre (VUMC) (Netherlands)80
招募中
不适用
Ovarian stimulation with r-FSH for women with high early follicular FSH and IUI indication.Subfertile women with elevated early follicular FSH valuesNL-OMON23707VU University Medical Center, Devision of Reproductive Medicine80
已完成
不适用
the STIM-trialbreast cancer, controlled ovarian stimulation, estradiol, tamoxifen, letrozole.borstkanker, ovariele stimulatie, oestradiol, tamoxifen, letrozol.NL-OMON21429Academical Medical Center159